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Abstract
Echocardiography plays a fundamental role in the evaluation of patients with an intracardiac mass. The ability to distinguish 
tissue characteristics, location, attachment, shape, size, and mobility non-invasively, quickly, and without the use of ionizing 
radiation makes echocardiography the ideal diagnostic modality. With careful attention to mass location and morphology, 
and appropriate application of clinical information, echocardiography can usually distinguish between the three principal 
intracardiac masses: tumor, thrombus, and vegetation. Equivocal transthoracic findings typically indicate the need for a 
transesophageal evaluation, during which the atria and great vessels might be better imaged. Surgical intervention is often 
indicated based on possible echocardiographic findings, without the need for additional time-consuming procedures. This 
review will focus on cardiac tumors.
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Introduction
Neoplasms of  the heart divided into primary cardiac tumors 
arising in the heart and secondary cardiac tumors that have 
metastasized to the heart. Primary cardiac tumors stratified into 
benign and malignant tumors. Secondary involvement of the 
heart is relatively uncommon; 10% to 20% of patients dying of 
disseminated cancer have metastatic involvement of the heart 
or pericardium.1,2 Primary tumors of the heart are uncommon 
but not rare. The incidence of primary cardiac neoplasm ranges 
between 0.17% and 0.19% in unselected autopsy series.3-8 
Approximately 75% of primary cardiac tumors are benign 
and 25% are malignant.2,9 Approximately 50% of the benign 
tumors are myxomas, and about 75% of the malignant 
tumors are sarcomas.2,9 Echocardiography is an invaluable 
technique for the evaluation of intracardiac masses, 
and can reliably identify mass location, attachment, shape, 
size, and mobility, while defining the presence and extent of 
any consequent hemodynamic derangement. With careful 
attention to mass location and morphology, and appropriate 
application of clinical information, echocardiography 
can usually distinguish between the three principal 
intracardiac mass lesions: tumor, thrombus, and vegetation. 
Transesophageal imaging frequently adds additional 
important information to the assessment of masses and should 
always be considered when image quality is inadequate or 
pertinent clinical questions remain unanswered with surface 
imaging. It can be performed at the bedside, operating theater 
and in critically ill patients.  However, echocardiographic 
image quality can be suboptimal, and ultrasound artifacts 
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can occasionally be mistaken for an anatomic mass. Careful 
identification of a mass lesion throughout the cardiac cycle 
in more than one imaging plane is an important first step in 
evaluating a suggested mass, and will decrease the likelihood 
of misinterpreting artifact as pathology. 
A thorough understanding of normal anatomy, normal 
variants, embryologic remnants, and the structural changes 
seen with certain operative and interventional procedures 
is crucial and will further avoid misdiagnosis. Finally, it is 
important that clinical and historic information be available 
and thoughtfully applied to the final echocardiographic 
interpretation.
Normal variants
Numerous normal anatomic variants exist that can easily 
be confused with primary mass lesions. In the left ventricle, 
webs and chords, prominent or calcified papillary muscles, 
prominent apical trabeculations, and dense mitral annular 
calcification (Figure 1) can mimic abnormal pathology. 
Ventricular noncompaction (Figure 2) and the apical form 
of hypertrophic cardiomyopathy can also be confused with 
tumors.10-13
ow)
Figure 1. Mitral annular calcification (MAC); apical four-chamber view 
showing significant calcification of posterior mitral annulus (arrow)
Figure 2. Non-compaction left ventricle; transgastric view showing markedly 
thickened two-layered myocardial wall with multiple trabeculations and 
deep intertrabecular recesses (arrow)
In the left atrium, beam-width artifacts can cause interpretive 
confusion, as can the suture lines associated with cardiac 
transplantation. Left atrium cords are rare but well-recognized 
findings. These cords typically originate at the atrial septum 
and insert into the atrial surface of the mitral leaflets; no clinical 
significance has ever been described. These cords should not 
be confused with true obstructive cor triatriatum. An interatrial 
septal aneurysm may appear as a cystic mass bulging into either 
atrium. A dilated coronary sinus can mimic an LA mass in the 
parasternal long axis view, as can a prominent descending aorta 
from the apical view. A left arm injection of agitated saline will 
define a persistent left superior vena cava draining into the 
coronary sinus, which is the most common structural anomaly 
associated with the dilatation of the coronary sinus. When a 
large accumulation of pericardial fluid is present, the transverse 
sinus can become prominent.
Pectinate muscles in the appendage can mimic a thrombus. 
An inverted left atrium appendage (a postoperative finding) 
can also be confused with a tumor.14,15 A hiatal hernia can 
impinge on both atria and can be confirmed after ingestion of 
carbonated beverage.
A prominent moderator band or tricuspid papillary muscles 
can create diagnostic confusion in the right ventricle. A fatty 
tricuspid annulus can be quite prominent. A substantial 
number of congenital remnants are seen in the right atrium, 
all of which can create diagnostic confusion.
The crista terminalis is a dense muscle ridge that extends 
between the right sides of the superior and inferior caval 
orifices and continues cephalad to open into the right atrium 
appendage (Figure 3). 
61The Journal of Tehran University Heart Center 
Echocardiographic Evaluation of Intracardiac Masses
A
B
Figure 3. Prominent crista terminalis (arrows); transthoracic (A) and 
transesophageal (B) views
It can be quite prominent but is commonly seen in the same 
image plane as the superior vena cava, which should be a 
clue to its identity.16 The Eustachian valve is an incompetent 
valve flap of variable thickness and mobility at the orifice of 
the inferior vena cava.
The Chiari network is a network of both coarse and fine 
fibers with attachments extending from the region of the 
crista terminalis to the Eustachian valve or floor of the right 
atrium (Figure 4). 
  Figure 4. The Chiari network (arrow); transesophageal view 
These fibers may become the site of thrombus formation 
or a catheter entrapment, requiring thoracotomy for retrieval; 
several recent reports describe entanglement of an atrial 
septal defect closure device and septal ablation guide wire in 
the Chiari network.17-19
Pectinate muscles can be seen on the right atrium appendage 
and the right atrium free wall and, when prominent, can 
mimic a thrombus. Venous varicose (clumps of veins) of the 
heart, rare lesions of unknown incidence and with no distinct 
or specific echocardiographic characteristics, are surprisingly 
well described in the pathology literature.20 They almost 
always occur in the right atrium at the posteroinferior border 
of the fossa ovalis. They are clumpy, dilated venous channels 
with irregular borders.21
Monitoring lines and pacer wires will also be evident in the 
right atrium and can occasionally become coiled, simulating 
a mass.
Fatty infiltrates of the atrial septum, termed as lipomatous 
hypertrophy, are preferential to the right atrium. Although 
they can occasionally be quite prominent (>6 cm), they 
should be distinguishable from a tumor by their typical 
location and shape.
Certain valvular structures can be confused with mass 
lesions as well. The nodules of Arantius and Lunula and 
the threadlike Lambl’s excrescences (Figure 5), which are 
commonly found on the aortic valve in patients older than 
60 years, can be confused with vegetations. Redundant 
supporting apparatus and redundant leaflet tissue of the 
mitral valve may mimic vegetations as well. Thoughtful 
application of clinical information is necessary to distinguish 
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degenerative from infectious processes. Excess epicardial fat 
may be confused with a tumor contained in the pericardium, 
as can fibrinous debris in the free pericardial fluid. Atelectatic 
segments of the lung can be misinterpreted as primary masses 
in the pleura.
Figure 5. Lambl’s excrescence of the aortic valve; mid esophageal long-axis 
view of  the Aorta (arrow)
Primary tumors
A primary cardiac neoplasm was first described by Realdo 
Colombo in 1559.22,23 Primary tumors of the heart and 
pericardium are difficult to diagnose because they are so 
uncommon and because their clinical presentation is so variable. 
The incidence of primary tumors at autopsy ranges from 0.002% 
to 0.3%.24,25 Approximately, 75% of primary cardiac tumors 
are benign. In adults, the most common cardiac tumor is the 
myxoma; in children younger than 15 years, the most common 
tumor is the rhabdomyoma.25 Of the primary malignant tumors, 
sarcomas are by far the most common, including angiosarcoma, 
rhabdomyosarcoma, and fibrosarcoma. Mesothelioma and 
primary intracardiac lymphoma comprise approximately 6% of 
the malignant tumors of the heart.26 Primary malignant cardiac 
tumors are rare in children.
Myxoma
Myxomas comprise 25% of all cardiac neoplasms and 
50% of benign cardiac tumors in adults but only 15% of such 
tumors in children. Myxomas usually occur sporadically and 
are more common in women than men.4,27
The peak incidence is between the third and sixth decades 
of life, and 94% of tumors are solitary.28 Tumors are unlikely 
to be associated with other abnormal conditions and have 
a low recurrence rate.4,28 However, they can be familial or 
complex (syndrome myxoma). Less than 10% of myxoma 
patients show a familial pattern based on autosomal 
dominance inheritance.29-30 These patients and 20% of those 
with sporadic myxomas have an abnormal DNA genotype 
chromosomal pattern.31 In contrast to “typical” sporadic 
myxomas, familial myxoma patients are more likely to be 
younger, equally likely to be male and female, and more 
often (22%) have multicentric tumors originating from either 
the atrium or the ventricle.32-37
Familial myxomas have a higher recurrence rate after 
surgical resection (21%- 67%).33,38,39 The familial variety may 
be part of a syndrome (Carney’s complex, NAME, LAMB), 
frequently includes multiple tumors in several chambers, and 
has a high rate of tumor recurrence.24 If the patient is young 
with multiple tumors, the screening of first-degree relatives 
is indicated. The complex variety, also known as Carney’s 
complex, may include a combination of the following: (1) 
multiple pigmented skin lesions (lentigines), (2) breast 
adenomas, (3) skin myxomas, (4) endocrine overactivity 
(e.g. pituitary adenomas), and (5) cardiac myxomas, often 
multiple.40,41 Syndrome myxomas are also occasionally 
referred to as the NAME syndrome (nevi, atrial myxoma, 
myxoid neurofibroma, and ephelides) or the LAMB syndrome 
(lentigines, atrial myxoma, and blue nevi).41
Myxomas occur in any chamber of the heart but have 
a special predilection for the left atrium, from which 
approximately 75% originate (Figure 6).42  
Figure 6. Large left atrial myxoma; transesophageal long-axis view showing 
the attachment of the tumor to the fossa region (arrow)
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The next most frequent site is the right atrium, where 
15-20% are found. The remaining 6% to 8% are equally 
distributed between the left and right ventricles.2 Both 
biatrial and multicentric tumors are more common in familial 
disease. Biatrial tumors probably arise from the bidirectional 
growth of a tumor originating within the atrial septum.43 Atrial 
myxomas generally arise from the interatrial septum at the 
border of the fossa ovalis but can originate anywhere within 
the atrium including the appendage.4 In addition, isolated 
reports confirm that myxomas arise from the cardiac valves, 
pulmonary artery and vein, and vena cava.44,45 Right atrial 
myxomas are more likely to have broad-based attachments than 
left atrial tumors; they also are more likely to be calcified and 
thus visible on chest radiographs.34,35  Ventricular myxomas occur 
more often in women and children and may be multicentric.2,46  
Right ventricular tumors typically arise from the free wall, and 
left ventricular tumors tend to originate in the proximity of the 
posterior papillary muscle.
Grossly, about two thirds of myxomas are round or oval tumors 
with a smooth or slightly lobulated surface.27 Most are polypoid, 
relatively compact, pedunculated, and mobile.2,4 Mobility 
depends on the length of the stalk and the extent of attachment 
to the heart.4 Sessile forms are unusual (approximately 10%).2,47 
Less common villous or papillary myxomas are gelatinous 
and fragile and prone to fragmentation and embolization, 
occurring about in one third.27,48 Focal areas of hemorrhage, 
cyst formation, or necrosis may be seen. The average size is 
about 5 cm in diameter but growth to 15 cm in diameter and 
larger has been reported. Most myxoma tumors appear to grow 
rapidly, but growth rates vary and occasionally tumor growth 
arrests spontaneously.4 Weights range from 8 to 175 g with a 
mean between 50 and 60 g.8 Work by Malekzadeh and Roberts 
suggests that myxomas grow on average 1.8 cm or 14 g each 
year. 49
The classic triad of myxoma clinical presentation is 
intracardiac obstruction with congestive heart failure (67%), 
signs of embolization (29%), systemic or constitutional 
symptoms of fever (19%) and weight loss or fatigue (17%), 
and immunologic manifestations of myalgia, weakness, and 
arthralgia (5%), with almost all patients presenting with one 
or more of these symptoms.27
Cardiac rhythm disturbances and infection occur less 
frequently. Myxomas in the left atrium tend to mimic mitral 
valvular heart disease. Large myxomas may interfere with 
mitral leaflet closure and produce mitral regurgitation. 
Syncopal episodes occur in some patients and are thought to 
result from the temporary occlusion of the mitral orifice.35,50,52 
Right atrial myxomas can produce a clinical picture of right 
heart failure with signs and symptoms of venous hypertension, 
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including hepatomegaly, ascites, and dependent edema. 
The tumor simulates tricuspid valve stenosis by partially 
obstructing the valve orifice.35,50-52 Systemic embolization 
occurs in 30% to 40% of patients.2,4,35,50,51 Because the 
majority of myxomas are left-sided, approximately 50% of 
embolic episodes affect the central nervous system owing to 
both intracranial and extracranial vascular obstruction.
Surgical removal of all varieties of myxomas is the 
treatment of choice. Echocardiography is very useful for the 
diagnosis and evaluation of myxomas. The sensitivity of 2-D 
echocardiography for myxomas is 100%.53
Color flow and spectral Doppler are useful to evaluate 
functional obstruction to LA emptying. Transthoracic 
echocardiography usually provides all the information for 
surgical resection, but transesophageal echocardiography 
provides the best information concerning tumor size, 
location, mobility, and attachment.54-55 Transesophageal 
echocardiography detects tumors as small as 1–3 mm in 
diameter.56 Additionally, intraoperative transesophageal 
echocardiography post-tumor excision is indicated to identify 
any residual tumor fragments prior to leaving the operating 
room. Recurrence of nonfamilial sporadic myxomas is 
approximately 1% to 4%.4,57,58 Many large series report no 
recurrent tumors.44,57,59,60 The disease-free interval averages 
about 4 years and can be as brief as 6 months.57 Most 
recurrent myxomas occur within the heart, in the same or 
different cardiac chambers, and may be multiple.35,61,62
The extent to which patients should be subjected to long-
term echocardiographic surveillance after myxoma resection 
is not standardized.
It would seem prudent to closely follow patients who are 
treated initially for multicentric tumors, those whose tumors 
are removed from unusual locations, tumors believed to 
have been incompletely resected, and those with abnormal 
DNA genotype.
Other benign cardiac tumors
Lipomas, papillary fibroelastomas, and rhabdomyomas are 
the most common benign tumors.
Papillary fibroelastoma
Papillary fibroelastomas are rare, primary benign cardiac 
tumors that are most frequently located in the cardiac valves 
or adjacent endocardium (Figure 7).63





Figure 7. Papillary fibroelastoma of the tricuspid valve; transthoracic 
subcostal view (A) and transesophageal view (B) showing large fibroelastoma 
attached to atrial surface of the anterior tricuspid valve leaflet (arrows)
Fibroelastomas are usually found by chance in post-
mortem examinations. It is now known that they are capable 
of producing the obstruction of th e flow, particularly the 
coronary ostial flow, and may embolize to the brain and 
produce stroke.64-66 They are usually asymptomatic until 
a critical event occurs. The prompt detection of papillary 
fibroelastomas is, therefore, of great importance. They are 
potential causes of systemic emboli, stroke, myocardial 
infarction, and sudden death.67-69 Right-sided localization 
is even rarer.70 In order of frequency, they are the third 
primary cardiac tumors after myxomas and lipomas.71 
Papillary fibroelastomas represent 7.9% of benign primary 
cardiac tumors in adults.63 Approximately, 90% of primary 
fibroelastomas arise from the valvular tissue, most commonly 
from the aortic or mitral valves.72,73
In a study including 162 patients with papillary 
fibroelastomas, the age ranged from 5 to 86 (mean 60±16 
years).74 They may be single or multiple occurring more 
frequently on the ventricular surface of the semi lunar valve 
and on the atrial surface of atrioventricular valves and may 
be pedunculated with some mobility.75,76 The tricuspid valve 
is most affected in children and the mitral and aortic valves 
in adults.76  On gross anatomical examination, they resemble 
a sea anemone, consisting of multiple fingerlike fronds. 
The pathogenesis of papillary fibroelastomas remains under 
discussion, but several possible explanations have been 
reported, including previous mechanical damage to the 
endothelium, iatrogenic factors, organizing thrombi, and a 
latent infectious mechanism due to cytomegalovirus.72,77,78 
With the advent of echocardiography, an increasing number 
of papillary fibroelastomas have been diagnosed. Typical 
echocardiographic features include the following:
1. Round, oval, or irregular appearance, with well-
demarcated borders and a homogenous texture.
2. Small mobile stalks in 50%. Those with stalks are 
mobile.74,79 
Sun et al. found that 99% of papillary fibroelastomas were 
<20mm in the largest diameter.74 The largest reported one is 
53 mm.80 Even though papillary fibroelastomas are classified 
as benign cardiac tumors, they often cause systemic embolic 
events such as cerebrovascular stroke and more rarely myocardial 
infarction.81 This occurs because of their very friable and soft 
texture as well as the creation of thrombi on their surface, which 
may later become embolic. Echocardiography is a reliable 
means of evaluating the extent and anatomic attachment of 
these very small tumors, but many go undetected. There are 
no significant characteristics that enable the differentiation 
of fibroelastomas from degenerative valve disease. Surgical 
excision may be indicated in patients with large, mobile, 
left-sided tumors. Surgical removal of right-sided papillary 
fibroelastomas in asymptomatic patients is indicated only for 
large mobile tumors. The presence of a patent foramen ovale 
with a sizable right to left shunt is an additional consideration 
for right-sided fibroelastomas. Asymptomatic patients with 
small left-sided non-mobile (no stalk) fibroelastomas are 
usually observed. However, fibroelastomas ≥1 cm, especially 
if mobile, should be considered for excision, including in 
patients with other cardiovascular diseases, young patients 
with low risk of surgery, and those with a high cumulative 
risk for embolization.74
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Rhabdomyoma
Rhabdomyomas are the most common cardiac tumors 
of infants and young children. They usually present 
during the first few days after birth. They are thought to 
be a myocardial hamartoma rather than a true neoplasm.82 
They have a strong association with tuberous sclerosis, a 
familial neurologic syndrome characterized by hamartomas, 
epilepsy, mental retardation, sebaceous adenomas, and 
skin lesions. One study indicated that 80% of patients with 
cardiac rhabdomyomas had tuberous sclerosis, and 60% of 
patients with tuberous sclerosis younger than 18 years had 
cardiac rhabdomyomas.83 The exceptional patient is one 
with a solitary, single rhabdomyoma who does not have or 
develop tuberous sclerosis. Over 90% of rhabdomyomas are 
multiple and occur with approximate equal frequency in both 
ventricles.83-85
The atrium is involved in fewer than 30% of patients. 
Pathologically, these tumors are firm, gray, and nodular and 
tend to project into the ventricular cavity. The most common 
presentation is heart failure caused by tumor obstruction of the 
cardiac chambers or valvular orifice flow. Clinical findings 
may mimic valvular or subvalvular stenosis. Arrhythmias, 
particularly ventricular tachycardia and sudden death, may 
be a presenting symptom.
Atrial tumors may produce atrial arrhythmias.86 When 
associated with mechanical complications such as outflow 
tract obstruction, surgical excision may be indicated. 
However, surgical intervention is usually not necessary in 
the asymptomatic patient.87,88
Fibroma
Fibromas are the second most common benign cardiac 
tumors, with over 83% occurring in children; most are 
diagnosed by age 2 years. These tumors are solitary, occur 
exclusively within the left ventricle and the ventricular 
septum, and are typically intramural.24 They commonly 
invade the septum, anterior apex, and free wall; and may 
appear as markedly disproportionate, irregular hypertrophy.
They affect both sexes equally. Fibromas are non-
encapsulated, firm, nodular, gray-white tumors that can 
become bulky. Calcium deposits or bone may occur within 
the tumor and occasionally are seen in radiography. These 
tumors are histologically benign but frequently have 
a malignant course. The majority of fibromas produce 
symptoms through chamber obstruction, interference with 
contraction accounting for lethal ventricular dysrhythmia, 
and intractable heart failure associated with dyspnea and 
fatigue.89-91
Depending on size and location, they may interfere with 
valve function, obstruct flow paths, or cause sudden death 
from conduction disturbances in up to 25% of patients.92 
Fibromas localized to the apex can be confused with thrombus 
or true apical hypertrophy, but perhaps can be distinguished 
by their abnormal texture. Intracardiac calcification on chest 
roentgenograms suggests the diagnosis, which is confirmed 
by echocardiography. Although successful surgical resection 
is common now, these tumors can be extensively infiltrative, 
and it is not always possible to completely remove the tumor 
and partial removal is only palliative and may cause further 
myocardial dysfunction92,93 Successful, complete excision is 
curative.93,94
Children with extensive fibromas have been treated by 
cardiac transplantation.90,95,96
Lipoma
Lipomas are well-encapsulated tumors composed of mature 
fat cells, and may occur anywhere in the heart (Figure 8).2 
Figure 8. Lipoma; parasternal long-axis view showing a very large 
encapsulated mass in the left atrioventricular groove (arrow)
The most common sites affected are the left ventricle, 
right atrium, and interatrial septum.24 They may occur at 
any age and have no sex predilection. Lipomas are slow 
growing and may attain considerable size (≥4 kg) before 
producing obstructive or arrhythmic symptoms.97 Many are 
asymptomatic and are discovered incidentally on routine 
chest roentgenogram, echocardiogram, or at surgery or 
autopsy.98,99
Subepicardial and intrapericardial lipomas tend to compress 
the heart, may be associated with pericardial effusion, and 
present as cardiac or mediastinal enlargement on chest 
radiograph. Subendocardial tumors may produce chamber 
obstruction. Lipomas lying within the myocardium or septum 
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can produce arrhythmias or conduction abnormalities.100,101 
Large tumors that produce severe symptoms should be 
resected. These tumors are not known to recur.
Lipomatous hypertrophy of the interatrial 
septum
Although lipomas are true neoplasms, lipomatous 
hypertrophy is a non-encapsulated accumulation of mature 
adipose tissue within the atrial septum.2 This abnormality, 
more common than cardiac lipomas, tends to be quite large 
(≥7 cm), favors the right atrium, and is a common finding in 
women who are elderly and obese as an incidental finding 
during a variety of cardiac imaging procedures.60,102
Echocardiographers should recognize this lesion by its 
characteristic dumbbell shape, the result of sparing of the 
fossa ovalis (Figure 9) with the preponderance of fat typically 
in the superior portion of the septum. When the atrial septum 
is massively infiltrated by fat, the amount of adipose tissue 
in other parts of the heart is always increased, particularly 
the right ventricle epicardial surface. The main problem is 
differentiation from a cardiac neoplasm.103 
Figure 9. Lipomatous hypertrophy of interatrial septum; typical dumbbell 
shape, the result of sparing of the fossa ovalis (arrow)
Magnetic resonance imaging is reliable in the 
characterization of fat if diagnostic issues remain.104,105
Various arrhythmias and conduction disturbances have 
been attributed to its presence, but a definite cause-and-
effect relationship has not been established.102 Arrhythmias 
or heart block are considered by some as an indication for 
resection, but data are lacking as to the long-term benefits 
from resection.106
Angiomas, teratomas, and mesotheliomas of the 
atrioventricular node and endocrine tumors are extremely 
rare, representing less than 7% of all cardiac tumors.26 
Angiomas are vascular tumors, and myocardial contrast 
echocardiography has been particularly useful in determining 
their vascular nature.107-109
Hemangioma
Primary hemangiomas of the heart were first described in 
1893. Mc Allister reviewed 533 primary tumors and cysts 
of the heart and pericardium, of which 15 (2.8%) were 
hemangiomas.110 They are rare benign primary cardiac 
tumors, with less than 100 cases described in the current 
cardiac literature.111
The origin of hemangiomas is uncertain; they are thought 
to be either true neoplasms or hamartomas. These tumors 
can be localized in any part of the heart and pericardium. 
They are commonly found in the interventricular septum or 
the atrioventricular node, where they can cause complete 
heart block and sudden death. In a previous review of 56 
cases of cardiac hemangiomas, 36% were found in the right 
ventricle, 34% in the left ventricle, 23% in the right atrium, 
and the rest on the interatrial septum (Figure 10) and in the 
left atrium.112 Histological patterns that have been described 
include capillary hemangiomas, cavernous hemangiomas, 
hemangioendotheliomas, and intramuscular hemangiomas.113 
Hemangiomas can present in any age group with a mild 
predominance in females. The symptomatology depends on 
the anatomic location and extension of the tumor. Although 
most cardiac hemangiomas are discovered incidentally, 
they may cause dyspnea, palpitation, atypical chest pain, 
arrhythmia, and pericardial effusion.114
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Figure 10. Cavernous Hemangioma; transthoracic subcostal (A) and 
transesophageal bicaval (B) views demonstrating large homogenous mass in 
interatrial septum bulging into right atrium (arrows) 
Echocardiography is usually the initial imaging modality 
and has an 81% accuracy rate in detecting cardiac tumors. 
Cardiac catheterization studies (particularly ventricular 
angiograms) can help to diagnose a cardiac tumor in 40% 
of cases by revealing an intracavitary filling defect. The 
classic finding on coronary arteriography is a vascular 
blush. Recently CT and MR have been used in preoperative 
diagnosis and in the evaluation of extra cardiac extension and 
myocardial involvement.115 Preoperative diagnosis of cardiac 
hemangiomas occurs in a minority of cases. The long-term 
prognosis is favorable after adequate surgical resection. 
Unresectable tumors have a poor prognosis and may lead to 
sudden death due to arrhythmias.
Teratoma
Cardiac teratomas are rare tumors that usually present in 
infants and young children but sometimes occur in adults.116 
About 80% of the tumors are benign and the remainders have 
microscopic or clinically malignant cells.117
Teratomas are usually found in the mediastinum. Rarely 
intracardiac, they are usually within the pericardial space. 
Teratomas have elements of all 3 germ cell layers, and 
can have skin, hair, and muscle. Large bloody pericardial 
effusions causing hemodynamic compromise are a well-
described presentation of these uncommon tumors.118,119 Fetal 
echocardiography has been useful in identifying mediastinal 
masses causing cardiac compression, with associated 
accumulations of pericardial fluid.
Mesothelioma of the atrioventricular node
Mesotheliomas of the atrioventricular node, also termed 
polycystic tumors, Purkinje tumors, or conduction tumors, 
are mentioned in the pathologic classification of tumors. 
They are relatively small, multicystic tumors that arise in 
proximity to the atrial ventricular node and may extend 
upward into the bundle of His.2
Mesotheliomas are associated with heart block, ventricular 
fibrillation,120 and sudden death. Cardiac pacing alone does 
not prevent subsequent ventricular fibrillation. Surgical 
excision has been reported.121
Pheochromocytoma
Cardiac pheochromocytomas arise from the chromaffin 
cells of the sympathetic nervous system and produce excess 
amounts of catecholamines, particularly norepinephrine. 
Approximately 90% of pheochromocytomas are in the 
adrenal glands. Fewer than 2% arise in the chest. These tumors 
predominantly affect young and middle-aged adults with an 
equal distribution between the sexes. Approximately 60% 
occur in the roof of the left atrium. The remainder involve the 
interatrial septum or anterior surface of the heart. The patients 
usually present with symptoms of uncontrolled hypertension. 
These tumors are usually located by scintigraphy and CT or 
MRI.122,123 Cardiac catheterization with differential blood 
chamber sampling is sometimes necessary.124 Because 
these tumors are vascular and may be near major coronary 
arteries, coronary arteries angiography is advised. After the 
tumor is located, it should be removed. Transplantation has 
been performed for unresectable tumors. Complete excision 
produces cure.122-124
Primary malignant tumors
Approximately, 25% of primary cardiac tumors are 
malignant; and of these, about 75% are sarcomas. 
McAllister’s survey of cardiac tumors found the most 
common to be angiosarcomas (31%), rhabdomyosarcomas 
(21%), malignant mesotheliomas (15%), and fibrosarcomas 
(11%).2 Primary malignant cardiac tumors are sporadic, 
showing no inherited linkage.
Sarcomas most commonly occur in patients between the 
ages of 30 and 50 years, are unusual in children, are typically 
found in the right heart chambers, and occur equally in 
men and women.24 There are several reports of sarcomas 
developing around surgically implanted Dacron grafts or 
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prosthetic valves, both in the heart and in other peripheral 
vascular sites.125-128 Cardiac sarcomas are characteristically 
very aggressive tumors and, once diagnosed, are associated 
with a downhill course. They grow rapidly, and death is usually 
the result of widespread infiltration of the myocardium or 
extensive distant metastasis. Sarcomas may cause right heart 
failure as a result of obstruction anywhere in the right heart 
inflow/outflow tract; penetration into the pericardial space 
and subsequent pericardial effusion may occur. Dysrhythmia 
is common. Cardiac findings are determined by the location 
of the tumor. Chest X-ray may be abnormal and even 
show a mass lesion, but the definite diagnosis is usually 
made via echocardiography.129,130  The echocardiographic 
characteristics of sarcomas are not specific, but sarcomas 
may attach at any site in the chamber, and many are sessile. 
A heterogeneous mass lesion in the right heart associated 
with dysrhythmia or conduction disturbance should include 
sarcoma in the differential. Right atrial lesions are more 
frequently malignant (usually angiosarcomas) than left-sided 
lesions (usually myxomas, but when malignant are often 
malignant fibrous histiocytomas). If malignancy is suspected, 
chest CT or MRI may suggest histology and provide detailed 
anatomy and help in staging and assessing resectability. 
Unfortunately, primary cardiac malignancy may grow to a 
large size prior to detection and involve portions of the heart 
not amenable to resection. Palliative medical therapy can 
be attempted with radiation therapy. Whether the tumor is 
primary or secondary, the decision to resect is based on the 
tumor size and location and an absence of metastatic spread.
Angiosarcoma
Angiosarcomas are two to three times more common 
in men than women and have a predilection for the right 
heart. Eighty percent arise in the right atrium.131-133 These 
tumors tend to be bulky and aggressively invade adjacent 
structures, including the great veins, tricuspid valve, right 
ventricular free wall, interventricular septum, and right 
coronary artery.132 Obstruction and right heart failure are 
not uncommon. Unfortunately, most of these tumors have 
spread by the time of presentation, usually to the lung, liver, 
and brain.131 Without resection, 90% of the patients are dead 
within 9 to 12 months after diagnosis despite radiation or 
chemotherapy.42,134
Malignant fibrous histiocytoma
Malignant fibrous histiocytomas are the most common 
soft-tissue sarcomas in adults. They are characterized 
histologically by a mixture of spindle cells, polygonal cells 
resembling histiocytes, and malignant giant cells. The cell of 
origin is the fibroblast or histioblast.129-135 They usually occur 
in the left atrium and often mimic myxomas. Their tendency 
to metastasize is not as prominent as that of angiosarcomas. 
Several reports exist with rapid symptomatic recurrence after 
incomplete resection despite chemotherapy.
Rhabdomyosarcoma
Rhabdomyosarcomas do not evolve from rhabdomyoma 
and occur equally in the sexes. The tumors are multicentric in 
60% of patients and arise from either ventricle. These tumors 
frequently invade cardiac valves or interfere with valve 
function because of their intracavitary bulk. These tumors 
are aggressive and may invade the pericardium. Surgical 
excision of small tumors may be rational but local and distant 
metastasis and poor response to radiation or chemotherapy 
limit survival to less than 12 months in the majority of these 
patients.94,116,117,130,136,137
Lymphomas
Lymphomas may, albeit rarely, arise from the heart.138 
Most of these tumors respond to radiation and chemotherapy. 
Even when complete resection is not possible and incomplete 
resection is performed to relieve acute obstructive systems, 
radiation and chemotherapy have allowed for up to 3-year 
survival in selected patients.
Metastatic tumors
Whereas primary tumors of the heart are rare, cardiac 
metastases have been described in up to 20% of patients 
with malignancies of other organ systems.2,5,9,139 Secondary 
neoplasms are 20 to 40 times more common than primary 
cardiac malignancies.4,26,140 No malignant tumor preferentially 
metastasizes to the heart, with the possible exception of 
malignant melanomas, which involve the heart in up to 
50% of patients.141 Cardiac lesions develop in up to 50% 
of patients with leukemia.5 Other cancers that commonly 
involve the heart include breast, lung, lymphoma, melanoma, 
and various sarcomas.2,142,143 Metastasis involves the 
pericardium, epicardium, myocardium, and endocardium.2,9 
Cardiac metastases are encountered typically in patients 
with widespread systemic tumor dissemination; even in 
this setting, the heart may still be spared tumor deposition 
because of vigorous cardiac contractility and rapid coronary 
blood flow. The tumors that most commonly manifest cardiac 
metastasis are lung, breast, ovarian, kidney, leukemia, 
lymphoma, esophageal, and, as noted, melanoma.24,26
Although solid intracardiac metastasis from melanomas 
is well described, the most common cardiac extension of 
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melanomas is subclinical and manifests as “charcoal” heart, 
with tumor studding the pericardial surface.144
Metastasis can reach the heart through hematogenous 
spread via coronary arteries, lymphatic channels, direct 
extension from adjacent lung, breast, esophageal and thymic 
tumors, and from the sub-diaphragmatic vena cava.24
Pericardial metastasis occurs more often than myocardial 
invasion by direct extension of thoracic cancer. The most 
common symptom is pericardial effusion with and without 
cardiac tamponade. The effusion may contain solid material 
adherent to the visceral or parietal pericardium; these masses 
may be tumors or may be clotted blood. Unfortunately, 
routine cytological examinations of the fluid are associated 
with a false-negative rate of perhaps as high as 20%.145 
Recurrent effusions are common, and pericardial window 
may be necessary. Solid pericardial metastasis that extends 
into cardiac chambers can be very aggressive, with the tumor 
expanding rapidly and causing significant hemodynamic 
derangement, including obstruction to cavity emptying and 
filling. Chemotherapy and tumor resection or debulking 
may alleviate symptoms and prolong survival. Occasionally, 
patients develop refractory arrhythmias or congestive 
heart failure.24 Echocardiography is particularly useful for the 
diagnosis of pericardial effusion, irregular pericardial thickening, 
or intracavitary masses interfering with the blood flow.
Right atrial extension of sub-diaphragmatic 
tumors
Both benign and malignant abdominal and pelvic tumors 
can extend to the heart through the inferior vena cava. Wilms’ 
tumors (common in children), uterine leiomyosarcomas, and 
hepatomas may also metastasize to the heart by the inferior 
vena cava. Of all the tumors that metastasize to the heart via 
the inferior vena cava, renal cell carcinomas (hypernephroma) 
are the most common. Up to 10% of renal cell carcinomas 
invade the inferior vena cava, and up to 43% of patients with 
this tumor demonstrate right atrium involvement.146,147
Their point of origin and extension into the inferior vena 
cava usually can distinguish these metastases from the typical 
myxomas, and this attachment is best imaged in the subcostal 
plane. Radiation and chemotherapy are not effective in 
relieving the obstruction of the blood flow. If the kidney can 
be fully removed as well as the tail of the tumor thrombus, 
survival can approach 75% at 5 years.92,148,149
Intravascular leiomyomatosis
The most commonly reported benign tumor with 
inferior vena cava intracardiac extension is intravascular 
leiomyomatosis of pelvic or uterine origin (Figure 11).
Figure 11. Intracardiac leiomyomatosis; transesophageal view of 
intracardiac leiomyomatosis invading right atrium (RA) by dilated inferior 
vena cava (IVC). Tumor is heterogeneous in appearance and abuts superior 
border of IVC (arrow).
Leiomyomatosis, a rare uterine tumor, is defined as the 
extension into the venous channels of a histologically benign 
smooth muscle tumor. As cardiac involvement is present in up 
to 10% of cases, it may be misdiagnosed as a primary cardiac 
tumor or venous thrombus-in-transit.150 It was first reported 
by Birch-Hirschfield in 1897,151 and the first case report in 
the English literature was published by Marshall and Morris 
in 1959.152 It generally occurs in women aged between 28 
and 80 years old, most patients being middle-aged women.153 
The patients often have a history of hysterectomy, or may 
have symptoms due to uterine fibroids. Cardiac involvement 
presents typically with right-sided congestive symptoms. 
There are, however, other presentations like syncope due to 
obstruction at the tricuspid valve. Rarer manifestations that have 
been reported include a high output state, secondary thrombosis 
with Budd-Chiari syndrome, massive ascites, sudden death, and 
systemic embolism. Metastasis to lungs and lymph nodes has 
been reported, and pulmonary nodules have been described. 
The most important condition in the differential diagnosis is 
thrombus-in-transit, which appears as elongated mobile masses 
of venous casts and gives a ‘‘popcorn’’ appearance within the 
cardiac chambers.150
Other tumors such as renal cell carcinoma and hepatomas 
may extend into the right-sided cardiac chambers via the inferior 
vena cava. Tumor removal may necessitate sternotomy as well 
as laparotomy.151 If the tumor is extensive, a two-stage operation 
may be needed.152 Recurrence after the surgical removal of the 
cardiac tumor is not unusual and can occur up to 15 years after 
surgery. Echocardiography may be useful for detecting cardiac 
recurrence and monitoring tumor growth.
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Carcinoid syndrome
The carcinoid syndrome (flushing, gastrointestinal hypermotility 
with secretory diarrhea, bronchospasm associated with wheezing, 
and carcinoid heart disease) results from circulating humoral 
substances secreted by the carcinoid tumor.154 Patients with 
primary carcinoid tumors of the ileum who have liver metastasis 
develop the distinctive lesions of the heart. These lesions are 
always located on the right and occasionally on the left side of 
the heart. When the primary carcinoid tumor is of a pulmonary 
bronchus, the carcinoid valvular lesions may be limited to the 
left-sided valves. In this setting, the liver may be tumor free.155 
Carcinoid valve lesions are characterized by plaque-like, fibrous 
endocardial thickening that causes retraction and fixation of the 
tricuspid and pulmonary valve leaflets.
Tricuspid regurgitation is a nearly universal finding; 
tricuspid stenosis, pulmonary regurgitation, and pulmonary 
stenosis may also occur.154 The lesion occurs nearly entirely 
on the downstream (ventricular) side of the septal and 
posterior tricuspid leaflets. On the anterior tricuspid leaflet, 
the deposits can occur on both sides, which results in the 
adherence of the leaflet to the underlying mural endocardium 
and in significant valvular incompetence and occasionally 
some degree of stenosis.154 The dominant pulmonic valve 
lesion tends to be stenosis. Carcinoid is the only condition in 
which both right-sided valves are uniformly involved, and the 
lesions are pulmonary stenosis and tricuspid regurgitation. 
The typical valve morphology is of rigid leaflets fixed in a 
semi-open position.
Surgical replacement of dysfunctional valves is described, 
but the mortality appears to be fairly high.156,157
Cardiac cysts
Although cardiac cysts are not true neoplasms, they are 
occasionally found within the heart and pericardium. The 
most common cysts are pericardial cysts, echinoccocal 
(hydatid) cysts, and blood cysts.
Echinococcosis
Hydatid disease is a parasitic infestation caused by the 
larvae of the tape form echinococcus. Cardiac involvement 
is rare, with a reported occurrence between 0.2- 2% of all 
hydatid diseases.158-161 Primary involvement of the heart 
usually occurs in 50% of cases via the coronary arteries. 
Secondary involvement of the heart occurs from the hydatid 
disease of the adjacent organs, such as lungs or from the 
dome of the liver. The left ventricle is affected most often 
(50-70%), followed by right ventricle pericardium (15-20%), 
and interventricular septum (5-15%).159,161,162 
Symptoms, signs, and potential complications depend on 
the location and the size of the cysts.158 Rupture, dysrhythmia, 
heart failure, and emboli are common and can result in 
death.158,159,163 Echocardiography, CT, and MRI might be 
used for the diagnosis. Transesophageal echocardiography 
shows the cystic nature of the mass, but sometimes the 
echolucent and multi-septated nature of lesions may be 
absent. Echocardiography cannot be used to differentiate 
hydatid cysts from congenital pericardial lesions. Computed 
tomography and MRI are superior to surrounding tissues. 
Calcifications are best seen on CT.158,163,164
The differential diagnosis of cardiac hydatid disease, 
other cystic masses, and tumor-like lesions of the heart 
such as myocardial aneurysms, pericardial cysts, and 
pleuropericardial masses should always be considered. 
Operation is the treatment of choice.165-169
Pericardial cysts
Pericardial cysts are rounded echolucent structures typically 
adjacent to the right atrium. The diagnosis can be made on 
chest radiograph. Pericardial cysts are usually asymptomatic, 
but can become quite large and cause compression of the right 
atrium and right ventricle and the surrounding mediastinal 
structures, including the bronchus and esophagus. Operation 
is indicated when significant symptoms dominate the clinical 
picture.170-173
Blood cysts
Blood cysts are congenital cysts typically found on the 
closure lines of the valvular endocardium. They appear as 
well-circumscribed masses with thin walls and an echolucent 
core. They are rare in adults, and only a few reports of 
prospective echocardiographic diagnosis are available. 
Careful echocardiographic monitoring of the cysts for 
changes in size and for the assessment of changes in cardiac 
function may be appropriate, and operation may be indicated 
when the cysts are noted to cause cardiac dysfunction.174-177
Conclusion
Echocardiography is the procedure of choice for the evaluation 
of intracardiac masses. Echocardiography should, therefore, 
be meticulously applied and data cautiously interpreted. The 
appropriate knowledge of and careful attention to cardiac 
anatomy, use of multiple scan planes, and application of clinical 
information are mandatory for the diagnosis.
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